Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
21.87 USD | +4.14% | +9.72% | +0.70% |
16/04 | Leerink Partners Starts AnaptysBio With Outperform Rating, $47 Price Target | MT |
11/04 | Wells Fargo Initiates AnaptysBio With Overweight Rating, $56 Price Target | MT |
- Stock Market
- Equities
- ANAB Stock
- News AnaptysBio, Inc.
- Analyst Reco.